Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.91 - $14.63 $1.1 Million - $17.7 Million
-1,207,443 Reduced 20.73%
4,618,415 $4.39 Million
Q2 2022

Aug 15, 2022

SELL
$0.89 - $2.47 $748,319 - $2.08 Million
-840,808 Reduced 12.61%
5,825,858 $6.7 Million
Q3 2021

Nov 15, 2021

BUY
$2.45 - $4.1 $16.3 Million - $27.3 Million
6,666,666 New
6,666,666 $20.3 Million

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $105M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.